ACE and diabetic kidney disease: Evidence from both animal and clinical studies supports the hypothesis that blockade of RAS by ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) is an effective strategy in treating diabetic kidney diseases 6.